BBWI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bath & Body Works Inc (BBWI) is not a strong buy at the moment for a beginner investor seeking long-term growth. The stock is experiencing a bearish technical trend, mixed analyst sentiment, and legal challenges, which make it less favorable for immediate investment. While there is potential for a modest recovery, the company's declining financial performance and lack of strong positive catalysts suggest holding off on purchasing this stock for now.
The stock is in a bearish trend with the MACD histogram at -0.179, RSI at 41.929 (neutral), and moving averages showing a bearish alignment (SMA_200 > SMA_20 > SMA_5). The current price of $22.45 is below the pivot level of $22.936, with key support at $21.568 and resistance at $24.303.
The stock also has a historical tendency to recover modestly over the next month, with a 70% chance of a 4.42% increase.
The company is facing multiple class-action lawsuits alleging financial missteps, which could weigh on investor sentiment. Financial performance in Q4 2026 showed declines across revenue (-2.26% YoY), net income (-11.04% YoY), and EPS (-5.69% YoY). Additionally, hedge funds and insiders remain neutral, showing no significant buying interest.
In Q4 2026, the company reported a revenue decline to $2.724 billion (-2.26% YoY), net income dropped to $403 million (-11.04% YoY), and EPS fell to $1.99 (-5.69% YoY). Gross margin also decreased to 45.67% (-2.16% YoY), indicating weaker profitability.
Analyst sentiment is mixed. Barclays raised its price target to $25 but maintained an Equal Weight rating. JPMorgan lowered its target to $22, citing execution risks. BofA and Wells Fargo are more optimistic, with targets of $30 and $29, respectively, citing turnaround efforts. However, Citi downgraded the stock to Neutral, citing weak core business and challenges in stabilizing sales.
